Display options
Cite
Koman A, Kolb VM, Terenius L. Prolonged receptor blockade by opioid receptor probes. Pharm Res. 1986;3(1):56-60doi: 10.1023/A:1016329000518.
Koman, A., Kolb, V. M., & Terenius, L. (1986). Prolonged receptor blockade by opioid receptor probes. Pharmaceutical research, 3(1), 56-60. https://doi.org/10.1023/A:1016329000518
Koman, A, et al. "Prolonged receptor blockade by opioid receptor probes." Pharmaceutical research vol. 3,1 (1986): 56-60. doi: https://doi.org/10.1023/A:1016329000518
Koman A, Kolb VM, Terenius L. Prolonged receptor blockade by opioid receptor probes. Pharm Res. 1986 Feb;3(1):56-60. doi: 10.1023/A:1016329000518. PMID: 24271359.
Copy Download .nbib Format: NLM
Share it on

Pharm Res. 1986 Feb;3(1):56-60. doi: 10.1023/A:1016329000518.

Prolonged receptor blockade by opioid receptor probes.

Pharmaceutical research

A Koman, V M Kolb, L Terenius

Affiliations

  1. Department of Pharmaceutical Pharmacology, Uppsala University, Biomedicum, Box 591, 751 24, Uppsala, Sweden.

PMID: 24271359 DOI: 10.1023/A:1016329000518

Abstract

Opioid receptor interactions of morphinan-type opioids derivatized at the C-6 carbon were investigated. The compounds, designed as probes for studying opioid receptors, were characterized with regard to affinity for the rat brain mu receptor by competition with tritium-labeled dihydromorphine ((3)H-DHM). All compounds were also screened for prolonged receptor blockade by preincubation of rat brain membranes with the compounds alone, followed by extensive washing, and incubation with (3)H-DHM. The apparent dissociation profiles of congeners with prolonged blockade were further studied in the presence and absence of physiological concentrations of salts. Under conditions that completely dissociate the parent opioids, naltrexone, naloxone, and oxymorphone, the derivative l-(N-fluoresceinyl naltrexone thiosemicarbazone (6-FNX) and the opioid-steroid hybrids naloxone estrone azine (N-EH) and androstene bisoxymorphone azine (O-AD-O) showed more persistent receptor blockade than the bivalent opioid naloxonazine (NAz). Neither chemical reactivity nor a bivalent opioid structure was found to be a prerequisite for prolonged receptor blockade.

References

  1. J Biol Chem. 1982 Apr 10;257(7):3389-96 - PubMed
  2. J Neurosci. 1982 May;2(5):572-6 - PubMed
  3. Life Sci. 1983;33 Suppl 1:419-22 - PubMed
  4. Acta Pharmacol Toxicol (Copenh). 1985 Feb;56(2):108-16 - PubMed
  5. FEBS Lett. 1974 Jul 15;43(2):169-75 - PubMed
  6. J Med Chem. 1983 Sep;26(9):1229-35 - PubMed
  7. Anal Biochem. 1980 Sep 1;107(1):220-39 - PubMed
  8. Pharm Res. 1985 Nov;2(6):266-71 - PubMed
  9. J Med Chem. 1980 Jun;23(6):674-6 - PubMed
  10. J Pharmacol Exp Ther. 1985 Jan;232(1):149-55 - PubMed
  11. J Med Chem. 1984 Oct;27(10):1325-35 - PubMed
  12. Acta Pharmacol Toxicol (Copenh). 1974 Jan;34(1):88-91 - PubMed
  13. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6666-70 - PubMed
  14. Life Sci. 1983;33 Suppl 1:423-6 - PubMed
  15. Naunyn Schmiedebergs Arch Pharmacol. 1985 Dec;331(4):355-8 - PubMed
  16. Anal Biochem. 1981 Jun;114(1):75-84 - PubMed
  17. Annu Rev Pharmacol. 1971;11:241-70 - PubMed

Publication Types